| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/31/2004 | CN1486368A Methods for the production of multimeric proteins, and related compositions |
| 03/31/2004 | CN1486365A Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 03/31/2004 | CN1486327A 载脂蛋白类似物 Apolipoprotein analogues |
| 03/31/2004 | CN1485341A Method for modifying growth factors by recombined technology |
| 03/31/2004 | CN1485340A Polypeptide-human transmembrane glycopeptide 25 and polynucleotide for encoding such polypeptide |
| 03/31/2004 | CN1485339A Polypeptide-human zinc finger protein 70 and polynucleotide for coding this polypeptide |
| 03/31/2004 | CN1485338A Polypeptide -Human vacuole carrier protein 13 and polynucleotide for encoding this polypeptide |
| 03/31/2004 | CN1485337A Polypeptide-human actin heavy chain 74 and polynucleotide for coding this polypeptide |
| 03/31/2004 | CN1485336A Polypeptide- human clathrin 82 and polynucleotide for coding such polypeptide |
| 03/31/2004 | CN1485335A Polypeptide-embryonic development protien 65 and polynucleotide for coding this polypeptide |
| 03/31/2004 | CN1485334A Polypeptide-human I complement receptor protein 222 and polynucleotide for coding such polypeptide |
| 03/31/2004 | CN1485333A Polypeptide-human X linked gene espression protein 14 and polynucleotide for encoding such polypeptide |
| 03/31/2004 | CN1485332A Polypeptide-human ª‰transducin 72 and polynucleotide for coding the same |
| 03/31/2004 | CN1485331A Active protein liquid of scorpion egg, its extraction process and use |
| 03/31/2004 | CN1144019C Ceramic packing with channels for thermal and catalytic bed |
| 03/31/2004 | CN1143895C Gene engineering process for preparing diad/triad fusion protein of erythrocyte growth factor with improved bioactivity |
| 03/31/2004 | CN1143892C Recombinant sendal virus |
| 03/31/2004 | CN1143865C Tumor necrosis factor - ª‡inhibiting peptide and the application thereof |
| 03/31/2004 | CN1143864C Affinity peptide of tumor necrosis factor - ª‡receptor and the application thereof |
| 03/31/2004 | CN1143679C Method and material for treating and preventing mucosal tissue inflammation |
| 03/30/2004 | US6713666 Invertase inhibitors and methods of use |
| 03/30/2004 | US6713665 Nucleotide sequences coding polypeptide for use in generating disease resistant plants |
| 03/30/2004 | US6713663 Flowering locus T (FT) and genetically modified plants having delayed flower development |
| 03/30/2004 | US6713662 Production of collagen in the milk of transgenic mammals |
| 03/30/2004 | US6713621 Chimeric compositions having multi-modalities are also provided which can affect a plurality of gene functions by interfering with splicing or translation as well as transcription |
| 03/30/2004 | US6713619 Nucleic acid probe capable of detecting a single base difference between a nucleotide sequence present in a previously isolated human ras oncogene and a nucleotide sequence present in a corresponding human ras protooncogene |
| 03/30/2004 | US6713616 Detecting binding |
| 03/30/2004 | US6713608 Purification of heat shock protein complexes; obtain sample containing peptides, polypeptides and proteins, incubate with chaperone proteins, expose to column, elute amd recover complexes |
| 03/30/2004 | US6713607 Effector proteins of Rapamycin |
| 03/30/2004 | US6713606 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 03/30/2004 | US6713605 Peptides can be used as medicaments that fight infection by attracting leukocytes to a wound site, yet restrict tissue damage at the wound site caused by excessive oxygen radicals produced by these leukocytes |
| 03/30/2004 | US6713604 Synthetic cyclic peptides that inhibit that binding |
| 03/30/2004 | US6713603 Adjusted nucleotide sequences for use as antisense tools in genetic engineering |
| 03/30/2004 | US6713602 Compounds that are not polynucleotides yet which bind to complementary dna and rna strands more strongly the corresponding dna |
| 03/30/2004 | US6713457 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed |
| 03/30/2004 | US6713453 Sustained release; drug delivery; tissue adhesive |
| 03/30/2004 | US6713452 Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 03/30/2004 | US6713451 Insulin-like growth factor agonist molecules |
| 03/30/2004 | US6713450 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
| 03/30/2004 | US6713449 Endcapped peptide sequence comprising 12 continuous residues in dimerization region or dna binding region of transcription factor; tumors, arteriosclerosis |
| 03/30/2004 | US6713445 Ikeyfts sequence 2 and lesyt sequence 1 |
| 03/30/2004 | US6713444 Antiprotease amino acid sequences |
| 03/30/2004 | US6713302 Growth differentiation factor-6 |
| 03/30/2004 | US6713301 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 03/30/2004 | US6713300 Purified nucleic acid molecule comprising a sequence encoding a retina-specific atp binding cassette transporter for detecting macular degeneration |
| 03/30/2004 | US6713296 Due to a deletion of at least 10 amino acids, neurovirulence is attenuated as compared to a naturally occurring varicella-zoster virus |
| 03/30/2004 | US6713293 Encapsulated cells containing an amplified expression vector as a drug delivery device |
| 03/30/2004 | US6713286 Purified fiv-141 virus; vaccines |
| 03/30/2004 | US6713284 Used to protect individuals against the pathologies resulting from exposure to one or several related staphylococcal and streptococcal toxins |
| 03/30/2004 | US6713283 Tyrosylprotein sulfotransferases |
| 03/30/2004 | US6713282 End selection in directed evolution |
| 03/30/2004 | US6713280 Peptides and other exogenous molecules is enhanced by conjugation to a carrier group |
| 03/30/2004 | US6713279 Targeting of a genetic vaccine to a particular tissue or cell type of interest by creating a library of mutant polypeptides and screening them against cell of interest |
| 03/30/2004 | US6713278 Isolated baculovirus viral particles obtained by a method of producing a recombinant membrane receptor protein by culturing an insect cell transfected with a baculovirus expression vector |
| 03/30/2004 | US6713277 Expression of nucleic acid molecule of invention suppresses obesity |
| 03/30/2004 | US6713276 Modulation of Aβ levels by β-secretase BACE2 |
| 03/30/2004 | US6713270 Dna encoding a novel steroid receptor is introduced into cell with reporter gene, potential ligand is incubated with cell, production of reporter protein means ligand binds receptor |
| 03/30/2004 | US6713266 Immunoassay method for measuring a cyclosporine and its metabolites |
| 03/30/2004 | US6713265 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 03/30/2004 | US6713255 DNA chip, PNA chip, and their preparation methods |
| 03/30/2004 | US6713249 Soild supports for use in monitoring osteogenesis |
| 03/30/2004 | US6713248 Methods for detection of gamma-secretase activity and identification of inhibitors thereof |
| 03/30/2004 | US6713246 Method of producing interleukin-1 receptor antagonist in a syringe filled with blood |
| 03/30/2004 | US6713173 Magnetic recording medium; metal or alloy ferromagnetic particles encapsulated within a protein, apoferritin |
| 03/30/2004 | US6713072 Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine |
| 03/30/2004 | US6713071 Proteins from actinobacillus pleuropneumoniae |
| 03/30/2004 | US6713070 Viral particles which are released after the infection with the human cytomegalovirus, and the use of said particles as a vaccine |
| 03/30/2004 | US6713069 Compositions and methods for detecting, preventing, and treating African Hemorrhagic Fever |
| 03/30/2004 | US6713066 Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 |
| 03/30/2004 | US6713063 Insecticides |
| 03/30/2004 | US6713062 Diagnostic, immunological and therapeutic applications, particularly those connected with peptic ulcers and cancers, respiratory diseases, sepsis and a variety of other conditions. |
| 03/30/2004 | US6713061 Death domain containing receptors |
| 03/30/2004 | US6713052 Cancer treatment |
| 03/30/2004 | US6713042 Ascorbic acid analogs for metalloradiopharmaceuticals |
| 03/30/2004 | CA2411508A1 Methods for polysaccharide adhesin synthesis modulation |
| 03/30/2004 | CA2274144C Somatostatin antagonists |
| 03/30/2004 | CA2235471C Dna encoding a plasminogen activating protein |
| 03/30/2004 | CA2136103C Antibiotic cryptdin peptides and methods of their use |
| 03/30/2004 | CA2087347C Heterohybridomas producing human monoclonal antibodies to hiv-1 |
| 03/27/2004 | CA2405652A1 Augmentation of k+ channel expression using adenoviral vectors |
| 03/25/2004 | WO2004025416A2 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 03/25/2004 | WO2004025302A2 Method for the identification of proteins specific for renal cell carcinoma and use thereof |
| 03/25/2004 | WO2004025298A1 Analyzing nerve cell damage |
| 03/25/2004 | WO2004025263A2 Protein and peptide expression for passive immunity |
| 03/25/2004 | WO2004025256A2 Viral deconstruction through capsid assembly in vitro |
| 03/25/2004 | WO2004024943A1 Method of screening insulin content enhancer |
| 03/25/2004 | WO2004024941A2 Biochemical methods for measuring metabolic fitness of tissues or whole organisms |
| 03/25/2004 | WO2004024937A2 Virulence-associated nucleic acids and proteins and uses thereof |
| 03/25/2004 | WO2004024936A2 Mutant forms of glutamate receptors mglur2 and mglur3 |
| 03/25/2004 | WO2004024925A2 Collectin-complement activating protein chimeras |
| 03/25/2004 | WO2004024922A1 Aspartyl protease inhibitor as a nematode allergen |
| 03/25/2004 | WO2004024911A1 Enhancers specific to motor nerve cells/sensory nerve cells |
| 03/25/2004 | WO2004024909A2 Recombinant colstridium neurotoxin fragments |
| 03/25/2004 | WO2004024904A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 03/25/2004 | WO2004024901A1 REGULATING β-CATENIN LEVELS |
| 03/25/2004 | WO2004024894A2 Methods of modulating inflammation by administration of interleukin-19 and inhibitors of il-19 binding |
| 03/25/2004 | WO2004024893A2 Nell-1 enhanced bone mineralization |
| 03/25/2004 | WO2004024892A2 Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis |
| 03/25/2004 | WO2004024891A2 MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE |
| 03/25/2004 | WO2004024890A2 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |